- Home
- MRK
as 05-09-2025 12:40pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | KENILWORTH |
| Market Cap: | 218.2B | IPO Year: | N/A |
| Target Price: | $115.93 | AVG Volume (30 days): | 15.6M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.88 | EPS Growth: | 667.14 |
| 52 Week Low/High: | $75.93 - $134.63 | Next Earning Date: | 04-24-2025 |
| Revenue: | $63,922,000,000 | Revenue Growth: | 4.10% |
| Revenue Growth (this year): | 2.31% | Revenue Growth (next year): | 6.35% |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 hours ago
Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings
Business Wire
a day ago
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto
Insider Monkey
2 days ago
Is Merck & Co., Inc. (MRK) the Best Dow Stock?
Simply Wall St.
2 days ago
Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health
Insider Monkey
2 days ago
Merck & Co., Inc. (MRK): A Bull Case Theory
Insider Monkey
2 days ago
Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential
Business Wire
2 days ago
Merck to Participate in the Bank of America 2025 Global Healthcare Conference
Investor's Business Daily
3 days ago
Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.